Workflow
2025生命组学大会在南京启幕 江北新区企业发布创新成果打破基因测序“卡脖子”困境
Yang Zi Wan Bao Wang·2025-11-14 10:54

Core Viewpoint - The 2025 Frontiers in Life Genomics Technology and Translation Conference was held in Nanjing, focusing on "technological innovation driving omics applications" and showcasing advancements in the life genomics field [1][3]. Group 1: Event Overview - The conference was co-hosted by Nanjing Zhenmai Biotechnology Co., Ltd. and Shenzhen Zhenmai Biotechnology Co., Ltd., featuring top scholars and industry leaders discussing cutting-edge technologies and their translation paths [1][3]. - The event emphasized four dimensions: frontier technology, scenario application, biometry, and achievement transformation, aiming to bridge the gap from innovation to implementation [3]. Group 2: Product Launches - Zhenmai Biotechnology launched three innovative products, including a high-throughput nucleic acid fragment analyzer, which addresses the long-standing reliance on imports in this field [1][5]. - The high-throughput nucleic acid fragment analyzer serves as a core device for "preoperative examination" in gene sequencing, enhancing sample library quality checks and increasing detection success rates [5][6]. Group 3: Technological Innovations - The CMS chemical technology introduced by Zhenmai achieves an error rate as low as 0.001%, enhancing the performance and reducing costs for applications requiring high precision, such as tumor early screening and organ transplant rejection monitoring [6]. - The spatial omics chip combines the functions of a "microscope" and a "sequencer," allowing precise recording of molecular positions within tissues, which aids in tumor research and Alzheimer's disease studies [6]. Group 4: Industry Impact - Zhenmai has established a comprehensive product array covering low, medium, high, and ultra-high throughput sequencing instruments, achieving 100% domestic production of core components and materials [8]. - The conference facilitated connections between research institutions, medical organizations, and enterprises, accelerating the validation and promotion of innovative technologies [8].